<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02604446</url>
  </required_header>
  <id_info>
    <org_study_id>TPO-150</org_study_id>
    <secondary_id>2015-000295-94</secondary_id>
    <nct_id>NCT02604446</nct_id>
  </id_info>
  <brief_title>Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty.Tapentadol vs Oxycodone vs Placebo</brief_title>
  <official_title>Depot-opioids for Pre- and Postoperative Pain Relief After Primary Knee Arthroplasty. A Double Blinded Randomized Controlled Study. Tapentadol vs Oxycodone vs Placebo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Olavs Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Olavs Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will provide knowledge about the use of long-acting opioids for pain relief after
      primary knee arthroplasty. The investigators will compare depot tapentadol, depot oxycodone
      and placebo for effect on pain relief and side effects. The three study groups reflect the
      three different postoperative pain regimens that have been used the last years at St. Olavs
      Hospital, so investigators know that no patient will receive an inadequate pain treatment.
      The purpose of the study is to find which of the three treatments that gives the best pain
      relief with the least amount of side effects. The results will be of use for postoperative
      pain treatment for knee arthroplasty, but also for other types of major surgery. Similar
      studies that are not sponsored by pharmaceutical industry have not been published yet.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area under curve (AUC) based on daily numeric rating score (NRS) scale 1-10 for pain by mobilization the first 8 postoperative days</measure>
    <time_frame>8 days</time_frame>
    <description>NRS-scores</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain at rest in the previous 24 hours</measure>
    <time_frame>8 days</time_frame>
    <description>NRS-scores 1-10 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>worst pain in the previous 24 hours</measure>
    <time_frame>8 days</time_frame>
    <description>NRS-scores 1-10 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of sleep in the previous night</measure>
    <time_frame>8 days</time_frame>
    <description>NRS-scores 1-10 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nausea in the previous 24 hours</measure>
    <time_frame>8 days</time_frame>
    <description>NRS-scores 1-10 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>obstipation in the previous 24 hours</measure>
    <time_frame>8 days</time_frame>
    <description>NRS-scores 1-10 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>dizziness in the previous 24 hours</measure>
    <time_frame>8 days</time_frame>
    <description>NRS-scores 1-10 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sedation in the previous 24 hours</measure>
    <time_frame>8 days</time_frame>
    <description>NRS-scores 1-10 scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>headache</measure>
    <time_frame>8 days in the previous 24 hours</time_frame>
    <description>NRS-scores 1-10 scale</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Joint Diseases</condition>
  <arm_group>
    <arm_group_label>Tapentadol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>depot Tapentadol in addition to usual pain treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxycodone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>depot Oxycodone in addition to usual pain treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>depot glucose placebo in addition to usual pain treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tapentadol</intervention_name>
    <arm_group_label>Tapentadol</arm_group_label>
    <other_name>Palexia Depot</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxycodone</intervention_name>
    <arm_group_label>Oxycodone</arm_group_label>
    <other_name>Oxycontin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Glucose</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>usual pain treatment</intervention_name>
    <description>premedication of Dexamethasone, Paracetamol, Vimovo; postoperative Paracetamol and Vimovo</description>
    <arm_group_label>Tapentadol</arm_group_label>
    <arm_group_label>Oxycodone</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  scheduled for knee arthroplasty at St. Olavs University Hospital

          -  consent in participation in the study

        Exclusion Criteria:

          -  Contraindications for any of the study drugs

          -  Lactose intolerance

          -  Known hypersensitivity against any of the additives

          -  Chronic Obstructive Pulmonary Disease (COPD) grade 3 or 4

          -  Paralytic ileus

          -  Known alcohol or medical addiction/abuse

          -  History of asthma, urticaria or allergic reaction caused by acetyl salicylic acid or
             other NSAIDs

          -  Peptic ulcer

          -  Hemophilia

          -  Gastrointestinal bleeding

          -  Cerebrovascular bleeding

          -  Inflammatory bowel disease (ulcerous colitis, Crohn disease)

          -  Concomitant use of the following drugs: ACE-inhibitors, AT2-blockers, SSRI,
             Anti-psychotic drugs, MAO-inhibitors, Atazanavir and Nelfinavir (medicine used for
             HIV-infection)

          -  Known kidney failure (creatinin level above reference value)

          -  Known heart failure (NYHA III-IV)

          -  Pregnancy

          -  Women in fertile age with risk of pregnancy

          -  Nursing women

          -  operated under general anesthesia without use of spinal anesthesia

          -  using opioids on a regular basis except users of codeine or tramadol, or known former
             abuse of opioids

          -  Cognitive failure or other factors which make follow up impossible (for example
             language difficulties)

          -  No cell phone or internet connection at home (making follow up difficult)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Petter Aadahl, md phd</last_name>
    <role>Study Director</role>
    <affiliation>St. Olavs Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Torbjørn Rian, md</last_name>
    <email>Torbjorn.Rian@stolav.no</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jan Gunnar Skogås, md phd?</last_name>
    <email>Jan.Gunnar.Skogas@stolav.no</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Anestesiavdelingen, St Olavs Hospital</name>
      <address>
        <city>Trondheim</city>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thorbjørn Rian, md</last_name>
      <email>Torbjorn.Rian@stolav.no</email>
    </contact>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 11, 2015</study_first_submitted>
  <study_first_submitted_qc>November 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2015</study_first_posted>
  <last_update_submitted>November 21, 2017</last_update_submitted>
  <last_update_submitted_qc>November 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Arthroplasty, Replacement, Knee</keyword>
  <keyword>Analgesics</keyword>
  <keyword>Administration and dosage</keyword>
  <keyword>Knee</keyword>
  <keyword>Postoperational care</keyword>
  <keyword>Pain management</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxycodone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

